Matthew Balk's Net Worth

$10 Million

Estimate Recalculated Apr 3, 2024 04:21PM EST

Who is Matthew Balk?

Matthew Balk has an estimated net worth of $10 Million. This is based on reported shares across multiple companies, which include QUANTRX BIOMEDICAL CORP, AzurRx BioPharma, Inc., and SILVERGRAPH INTERNATIONAL INC.

SEC CIK

Matthew Balk's CIK is 0001217674

Past Insider Trading and Trends

2007 was Matthew Balk's most active year for acquiring shares with 1 total transactions. Matthew Balk's most active month to acquire stocks was the month of February. 2017 was Matthew Balk's most active year for disposing of shares, totalling 4 transactions. Matthew Balk's most active month to dispose stocks was the month of May. 2007 saw Matthew Balk paying a total of $0.00 for 105,300 shares, this is the most they've acquired in one year. In 2017 Matthew Balk cashed out on 320,000 shares for a total of $1,020,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

QUANTRX BIOMEDICAL CORP (QTXB) Snapshot price: $0.0049

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Mar 9
Form 3
—
0
—
—
0
No matching records found

AzurRx BioPharma, Inc. (FWBI) Snapshot price: $5.525

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
-8.95%
-160.00K
$3.19
-$510,000.00
1.63M
Jun 30
Form 4
-8.48%
-160.00K
$3.19
-$510,000.00
1.73M
Jun 30
Form 4
-0.85%
-15.35K
—
—
1.79M
Oct 11
Form 3
—
0
—
—
0
No matching records found

SILVERGRAPH INTERNATIONAL INC No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 3
—
0
—
—
0
No matching records found